UNSPSC 85815229: Introduction of anti-inflammatory into respiratory tract, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into respiratory tract, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F73Z

UNSPSC 85815229 Introduction of anti-inflammatory into respiratory tract, via natural or artificial opening is a Commodity code that does not align with the recent state and local procurement activity posted under it. The most recent opportunities tagged to this code—including virtual urgent care services, occupational health examinations, orthotic equipment, radiology reads, and wellness program platforms—are not respiratory medication administration services and reflect a data-classification mismatch rather than authentic buying activity under the code's stated scope.

The few postings nominally tied to 85815229 do not form a coherent procurement market. State and local issuers soliciting under this code include county health systems (Santa Clara, DeKalb County), state health authorities (Nevada Health Authority), public hospital networks (San Mateo Medical Center), and state departments (Illinois Secretary of State, Texas Health and Human Services Commission), but their activity spans telehealth evaluation, cancer registry services, occupational health screening, and radiology services—none of which involve anti-inflammatory medication delivery into the respiratory tract. Geographic reach spans California, Georgia, Nevada, Texas, Illinois, and other states, but purchasing concentration and repeat-buyer patterns cannot be meaningfully characterized because the code appears to be a tagging error rather than an active procurement category. Without authentic opportunities anchored to respiratory anti-inflammatory medication administration, this code presents minimal decision relevance for business development professionals. Vendors with clinical expertise in respiratory medication delivery or pulmonary therapeutics should verify the correct UNSPSC classification for their service line rather than rely on this code's current posting.